Hydrolyzed Collagen and Undenatured Collagen Type II in OA Knee
Launched by PRINCE OF SONGKLA UNIVERSITY · Jan 25, 2024
Trial Information
Current as of July 01, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age: 50-80 years old
- • Medial compartment knee osteoarthritis
- • Kellgren and Lawrence classification stage 2 -3
- • Able to walk without walking aid
- Exclusion Criteria:
- • History of knee surgery on the study side
- • History of intra-articular steroid injection within 6 months prior to study entry
- • Systemic arthritis conditions
- • Degenerative neurological and muscular conditions in the lower extremities
- • Chronic kidney disease with CrCl \< 30 ml/min (glomerular filtration rate \<60 mL/min/1.73 m2)
About Prince Of Songkla University
Prince of Songkla University (PSU) is a prestigious academic institution located in Thailand, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, PSU leverages its extensive resources and expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among multidisciplinary teams of researchers, healthcare professionals, and students, ensuring rigorous study designs and adherence to ethical standards. PSU's dedication to improving public health outcomes is reflected in its focus on translating research findings into practical applications that benefit local and global communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hat Yai, Songkhla, Thailand
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported